Clincosm LogoSign in Get a demo

urothelial cancer

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)

Recruiting
  • Urothelial Cancer
  • Nivolumab
  • +4 more
  • Birmingham, Alabama
  • +196 more
Jan 17, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Stanford, California
  • +15 more
Dec 21, 2022

Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

Terminated
Has Results
  • Colorectal Cancer
  • +6 more
  • GEN1029 (HexaBody®-DR5/DR5)
  • New Haven, Connecticut
  • +5 more
Nov 11, 2022

Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

Recruiting
  • Advanced Solid Tumor Historically Known for High EphA2 Expression
  • +6 more
  • Encinitas, California
  • +27 more
Aug 17, 2022

Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

Recruiting
  • Urothelial Cancer
  • Anchorage, Alaska
  • +414 more
Jul 14, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

Completed
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
Jan 4, 2022